Back to Journals » Clinical Ophthalmology » Volume 4

Is monthly retreatment with intravitreal bevacizumab (Avastin®) necessary in neovascular age-related macular degeneration?

Total article views   HTML views PDF downloads Totals
8,725 Dovepress* 8,725+ 1,979 10,704
Totals 8,725 1,979 10,704
*Since 8 April 2010
+Since July 2016

View citations on Google Scholar